4.3 Article

Ocrelizumab reduces thalamic volume loss in patients with RMS and PPMS

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Clinical Neurology

Effect of disease-modifying therapies on subcortical gray matter atrophy in multiple sclerosis

Elias S. Sotirchos et al.

MULTIPLE SCLEROSIS JOURNAL (2020)

Article Clinical Neurology

Intrinsic and Extrinsic Mechanisms of Thalamic Pathology in Multiple Sclerosis

Kedar R. Mahajan et al.

ANNALS OF NEUROLOGY (2020)

Article Clinical Neurology

Deep gray matter volume loss drives disability worsening in multiple sclerosis

Arman Eshaghi et al.

ANNALS OF NEUROLOGY (2018)

Article Medicine, General & Internal

Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis

S. L. Hauser et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Medicine, General & Internal

Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis

X. Montalban et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Review Biochemistry & Molecular Biology

Thalamus pathology in multiple sclerosis: from biology to clinical application

Markus Kipp et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2015)

Article Clinical Neurology

Early CNS neurodegeneration in radiologically isolated syndrome

Christina J. Azevedo et al.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2015)

Article Clinical Neurology

Placebo-controlled trial of oral laquinimod in multiple sclerosis: MRI evidence of an effect on brain tissue damage

Massimo Filippi et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2014)

Article Clinical Neurology

Multiple sclerosis deep grey matter: the relation between demyelination, neurodegeneration, inflammation and iron

Lukas Haider et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2014)

Article Clinical Neurology

The effect of daclizumab on brain atrophy in relapsing-remitting multiple sclerosis

Isabela T. Borges et al.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2013)

Article Clinical Neurology

Thalamic Damage Predicts the Evolution of Primary-Progressive Multiple Sclerosis at 5 Years

S. Mesaros et al.

AMERICAN JOURNAL OF NEURORADIOLOGY (2011)

Article Clinical Neurology

Diagnostic Criteria for Multiple Sclerosis: 2010 Revisions to the McDonald Criteria

Chris H. Polman et al.

ANNALS OF NEUROLOGY (2011)

Article Neurosciences

Regional brain atrophy in children with multiple sclerosis

B. Aubert-Broche et al.

NEUROIMAGE (2011)

Article Radiology, Nuclear Medicine & Medical Imaging

Thalamic Damage and Long-term Progression of Disability in Multiple Sclerosis

Maria Assunta Rocca et al.

RADIOLOGY (2010)

Article Clinical Neurology

Connecting white matter injury and thalamic atrophy in clinically isolated syndromes

Roland G. Henry et al.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2009)

Article Clinical Neurology

Regional grey matter atrophy in clinically isolated syndromes at presentation

R. G. Henry et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2008)

Article Clinical Neurology

Thalamic atrophy and cognition in multiple sclerosis

M. K. Houtchens et al.

NEUROLOGY (2007)

Article Clinical Neurology

Grey matter pathology in multiple sclerosis

M Vercellino et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2005)

Article Clinical Neurology

Diagnostic criteria for multiple sclerosis: 2005 Revisions to the McDonald Criteria

CH Polman et al.

ANNALS OF NEUROLOGY (2005)

Article Clinical Neurology

Thalamic neurodegeneration in multiple sclerosis

A Cifelli et al.

ANNALS OF NEUROLOGY (2002)